Medexus Pharmaceuticals, Inc. (MDP.TO)
2.81
-0.03
(-1.06%)
CAD |
TSX |
Feb 11, 16:00
Medexus Pharmaceuticals Profit Margin (Quarterly) : -1.27% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cannara Biotech, Inc. | 3.45% |
| NexgenRx, Inc. | 14.04% |
| Aurora Spine Corp. | -3.21% |
| Cronos Group, Inc. | 77.94% |
| NeuPath Health, Inc. | -0.43% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.82% |
| Return on Assets | 0.24% |
| Return on Invested Capital | 0.47% |
| Gross Profit Margin (Quarterly) | 54.31% |
| Operating Margin (Quarterly) | 5.57% |
| Return on Net Operating Assets | 0.28% |